Paper Details

Paper Title

Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis.

Paper Journal Title

Nat Commun

Paper Citation Count

Paper Publication Year

2022

Bio Mention

Mesh Descriptor

Column Actions